Esther Rose
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 2%
- Acute Myeloid Leukemia Research
Papers in
- Co-authors
- Louis M. Aledort (1 shared paper)David Hakimian (5 shared papers)D. Janson (1 shared paper)Mark A. Hoffman (1 shared paper)MS Tallman (3 shared papers)Richard Alan Nelson (2 shared papers)Craig Tendler (1 shared paper)David L. Cutler (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (7 papers)Cancer (1 paper)British Journal of Haematology (1 paper)Annals of Internal Medicine (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Esther Rose
21 papers receiving 937 citations
Peers
Comparison fields: 5 of 64
- Genetics 624
- Hematology 357
- Pathology and Forensic Medicine 335
- Immunology 251
- Oncology 253
Countries citing papers authored by Esther Rose
This map shows the geographic impact of Esther Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Rose more than expected).
Fields of papers citing papers by Esther Rose
This network shows the impact of papers produced by Esther Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Rose. The network helps show where Esther Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Esther Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 118 | |
| 2 | 1997 | 99 | |
| 3 | 1994 | 95 | |
| 4 | 1992 | 94 | |
| 5 | 1991 | 91 | |
| 6 | 1995 | 80 | |
| 7 | 1996 | 78 | |
| 8 | 2000 | 71 | |
| 9 | 1995 | 53 | |
| 10 | 2001 | 50 | |
| 11 | 1996 | 37 | |
| 12 | 2018 | 29 | |
| 13 | 1994 | 19 | |
| 14 | 1990 | 14 | |
| 15 | 2018 | 9 | |
| 16 | 2014 | 7 | |
| 17 | Efficacy and safety of recombinant human erythropoietin r huepo in anemic patients with myelodysplastic syndromes | 1991 | 6 |
| 18 | 2020 | 6 | |
| 19 | 1992 | 6 | |
| 20 | 2015 | 4 |
About Esther Rose
Esther Rose is a scholar working on Genetics, Oncology, Hematology, Pathology and Forensic Medicine and Molecular Biology, having authored 21 papers that have together received 968 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Viral-associated cancers and disorders (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (3 papers), Erythropoietin and Anemia Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (624 citations), Hematology (357 citations), Pathology and Forensic Medicine (335 citations), Immunology (251 citations) and Oncology (253 citations). Esther Rose has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Louis M. Aledort, David Hakimian, D. Janson, Mark A. Hoffman, MS Tallman, Richard Alan Nelson, Craig Tendler, David L. Cutler, Paul Statkevich and Daina Variakojis. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, British Journal of Haematology and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.